Deep inside its labs, Monsanto is learning how to modify crops by spraying them with RNA rather than tinkering with their genes.
A company started by several gene-editing pioneers gets new funding to develop treatments for blood cancers, eye diseases, and sickle-cell anemia.
A biotech company is genetically engineering pigs so that their organs might work in people.
New computer simulations illustrate the limits of prosthetic eyes and suggest pathways for making them better.
Glue made of nanoparticles, delivered by a needle, can be a better replacement for sutures and surgical staples.
A tiny, biologically inspired motion sensor could help small drones avoid collisions as they buzz around.
Monsanto no longer controls one of the biggest innovations in the history of agriculture.
Researchers have created self-contained cellular biolasers.
Scientists are now able to study the folding and unfolding of a protein over time, thanks to a new microscope device.
New antibody drugs show promise in slowing the advance of Alzheimer’s disease.